Description
An NAAA inhibitor (IC50s = 27 and 63 nM for the human and rat enzyme, respectively); selective for NAAA over FAAH and acid ceramidase (IC50s = >100 and 12.5 μM, respectively), as well as a panel of 28 enzymes at 10 μM; decreases lung myeloperoxidase activity and pleural exudate TNF-α levels in a mouse model of carrageenan-induced lung inflammation from 1-30 mg/kg; inhibits NAAA and reverses complete Freund’s adjuvant-induced decreases in PEA and OEA levels in inflamed paw tissue in a rat model of arthritis
Formal name: N-[(3S)-2-oxo-3-azetidinyl]-carbamic acid, 4-cyclohexylbutyl ester
Synonyms:
Molecular weight: 268.4
CAS: 1628343-77-0
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Immunology & Inflammation|Arthritis (Non-autoimmune)||Research Area|Immunology & Inflammation|Pulmonary Diseases||Research Area|Neuroscience|Cannabinoid Research|Endocannabinoids